Vanderbilt Training Program in Academic Cancer Research

范德比尔特学术癌症研究培训计划

• 批准号: 7232823
• 负责人: DAVID H JOHNSON
• 金额: $ 13.76万
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-07-01 至 2012-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7232823
• 关键词: Training Programs; anticancer research

DESCRIPTION (provided by applicant): Progress against cancer includes our ability to provide quality cancer care and support research within clinical trials. However, there is a significant shortage of well-trained oncologists/hematologists capable of comprehensive study of clinically-relevant problems; successful design and conduct of clinical trials to improve prevention, detection and treatment of human cancer; and most importantly, the translation of fundamental knowledge and new technologies between the laboratory, clinic, and community. The development of successful, independent translational cancer investigators requires adequate protected time and a strong mentorship in a rich research environment and well organized training program. The Vanderbilt-lngram Cancer Center, a matrix center within Vanderbilt Medical Center, is well-suited to support such a comprehensive training program due to its integrated cancer-related expertise and resources. The objective of the Vanderbilt Training Program in Academic Cancer Research is to train and support medical oncology/hematology fellows to ensure their success to meet new challenges and opportunities in all aspects of academic medical oncology/hematology. Candidates will be recruited from the Division of Hematology and Oncology Fellowship Program. Applicants accepted will participate in a comprehensive two-year training program consisting of two training tracks: (1) Clinical-Investigator Track will focus on the development and conduct of clinical trials and associated correlative studies (2) Physician-Scientist Track will focus on laboratory-based research. Fellows who complete either training track will be eligible for ABIM subspecialty certification in medical oncology and hematology. Upon completion of the program, trainees will be able to successfully function in a collaborative team environment, develop and lead independent research programs through hypothesis-driven research, obtain peer-reviewed grant support, communicate their research findings through presentations and publication in peer-reviewed journals, and provide high quality cancer care. To help ensure success, 100% of the program faculty have peer-reviewed support for cancer research and are actively conducting clinical and/or laboratory-based cancer research, consistently published in the best journals, have demonstrated mentorship abilities, and actively manage successful research programs. Support is being requested for two training positions per year.

描述(由申请人提供)：抗癌进展包括我们在临床试验中提供高质量癌症护理和支持研究的能力。然而，训练有素的肿瘤学家/血液学家严重缺乏能够全面研究临床相关问题的能力；能够成功地设计和实施临床试验以改进人类癌症的预防、检测和治疗；最重要的是，能够在实验室、临床和社区之间转化基本知识和新技术。成功的、独立的癌症翻译研究人员的发展需要充足的保护时间和在丰富的研究环境和组织良好的培训计划中的强大指导。范德比尔特-英格拉姆癌症中心是范德比尔特医疗中心内的一个矩阵中心，由于其整合的癌症相关专业知识和资源，非常适合支持这样一个全面的培训计划。范德比尔特学术癌症研究培训计划的目标是培训和支持医学肿瘤学/血液学研究员，以确保他们成功迎接学术肿瘤学/血液学各方面的新挑战和新机遇。候选人将从血液学和肿瘤科奖学金计划中招募。被录取的申请者将参加一个为期两年的综合培训计划，该计划包括两个培训路径：(1)临床-研究人员路径将侧重于临床试验和相关研究的开发和实施(2)医生-科学家路径将侧重于基于实验室的研究。完成任何一项培训的学员将有资格获得ABIM内科肿瘤学和血液学专业认证。计划完成后，学员将能够在协作的团队环境中成功发挥作用，通过假设驱动的研究开发和领导独立研究计划，获得同行评审的拨款支持，通过在同行评审的期刊上发表演讲和发表文章来交流他们的研究结果，并提供高质量的癌症护理。为了帮助确保成功，100%的项目教职员工都对癌症研究提供了同行评议的支持，并积极开展临床和/或基于实验室的癌症研究，在最好的期刊上始终如一地发表文章，证明了指导能力，并积极管理成功的研究项目。要求为每年两个培训职位提供支助。